HARROW, INC. — Director's Dealing 2007

Dec 27, 2007

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: TRANSDEL PHARMACEUTICALS INC (TDLP)
CIK: 0001360214
Period of Report: 2007-12-27

Reporting Person: THORNLEY ANTHONY S (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, par value $0.001 per share	50000	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Warrants	$	2012-10-10	Common Stock (12500)		Direct
Option (Right to Buy)	$2.58	2017-12-04	Common Stock (10000)		Direct

Footnotes

F1: The warrants have a cash exercise price equal to $4.00 per share and a cashless exercise price equal to $5.00 per share.